Search Results

Effects of α-Adrenoceptor Antagonist Doxazosin on MDR1-Mediated Multidrug Resistance and Transcellular Transport

Authors: Takara, Kohji; Sakaeda, Toshiyuki; Kakumoto, Mikio; Tanigawara, Yusuke; Kobayashi, Hironao; Okumura, Katsuhiko; Ohnishi, Noriaki; Yokoyama, Teruyoshi

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 17, Numbers 11-12, 2009 , pp. 527-533(7)

Publisher: Cognizant Communication Corporation

Doxazosin: Retrograde ejaculation: case report

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 13-13(1)

Publisher: Adis International

Heart Failure in ALLHAT: Did Blood Pressure Medication at Study Entry Influence Outcome?

Authors: Grimm, Richard H.; Davis, Barry R.; Piller, Linda B.; Cutler, Jeffrey A.; Margolis, Karen L.; Barzilay, Joshua; Dart, Richard A.; Graumlich, James F.; Murden, Robert A.; Randall, Otelio S.

Source: The Journal of Clinical Hypertension, Volume 11, Number 9, September 2009 , pp. 466-474(9)

Publisher: Blackwell Publishing

Silodosin: an orally active selective α₁-adrenoceptor antagonist for benign prostatic hyperplasia

Author: Guay, David RP

Source: Aging Health, Volume 5, Number 4, August 2009 , pp. 459-473(15)

Publisher: Future Medicine

Bisoprolol/doxazosin/valsartan: Sarcoidosis to anhydrous colloidal silica excipient: case report

Source: Reactions, Volume 1, Number 1262, 2009-07-25 , pp. 8-8(1)

Publisher: Adis International

α-blockers: interaction with PDE-5 inhibitors highlighted on labels

Source: Reactions, Volume 1, Number 1253, 2009-05-23 , pp. 2-2(1)

Publisher: Adis International

Higher risk of IFIS with tamsulosin

Source: Reactions, Volume 1, Number 1250, 2009-05-02 , pp. 4-4(1)

Publisher: Adis International

Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension

Authors: Ceral, Jiri; Solar, Miroslav

Source: Blood Pressure, Volume 18, Numbers 1-2, April 2009 , pp. 74-77(4)

Publisher: Informa Healthcare

Combination of Doxazosin and Sildenafil Exerts an Additive Relaxing Effect Compared with Each Compound Alone on Human Cavernosal and Prostatic Tissue

Authors: Oger, Stéphanie; Behr-Roussel, Delphine; Gorny, Diane; Lecoz, Olivier; Lebret, Thierry; Denoux, Yves; Faix, Antoine; Leriche, Albert; Wayman, Chris; Alexandre, Laurent; Giuliano, François

Source: The Journal of Sexual Medicine, Volume 6, Number 3, March 2009 , pp. 836-847(12)

Publisher: Blackwell Publishing

Current role of α-blockers in the treatment of benign prostatic hyperplasia

Author: Kaplan, Steven A.

Source: BJU International, Volume 102, Supplement 2, November 2008 , pp. 3-7(5)

Publisher: Blackwell Publishing

Antihypertensives: Renal hypoperfusion in an allograft from a hypertensive donor: case report

Source: Reactions, Volume 1, Number 1218, 2008-09-06 , pp. 6-7(2)

Publisher: Adis International

A meta-analysis of the vascular-related safety profile and efficacy of α-adrenergic blockers for symptoms related to benign prostatic hyperplasia

Authors: Nickel, J. C.; Sander, S.; Moon, T. D.

Source: International Journal of Clinical Practice, Volume 62, Number 10, October 2008 , pp. 1547-1559(13)

Publisher: Blackwell Publishing

The use of finasteride long term, either alone or in combination with doxazosin, reduces total prostate volume

Source: Inpharma, Volume 1, Number 1652, 2008-08-23 , pp. 10-10(1)

Publisher: Adis International

Pharmacological management of uncomplicated renal colic in elderly patients requires control of acute pain and perhaps medical expulsion therapy

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 7, July 2008 , pp. 14-17(4)

Publisher: Adis International

In vivo administration of doxazosin in rats highly decreases serum circulating levels of testosterone through a mechanism involving the testicular renin-angiotensin system

Authors: de la Chica-Rodríguez, S.; Cortés-Denia, P.; Ramírez-Expósito, M. J.; Arias de Saavedra, J. M.; Sánchez-Agesta, R.; del Cármen Pérez, M.; Martínez-Martos, J. M.

Source: International Journal of Andrology, Volume 31, Number 3, June 2008 , pp. 364-370(7)

Publisher: Blackwell Publishing

Doxazosin reduces cell proliferation and increases collagen fibers in rat prostatic lobes

Authors: Justulin, Luis; Delella, Flavia; Felisbino, Sérgio

Source: Cell and Tissue Research, Volume 332, Number 1, April 2008 , pp. 171-183(13)

Publisher: Springer

Involvement of transcription factor activator protein-2α in doxazosin-induced HeLa cell apoptosis

Authors: GAN, Lu; ZHU, Dong-xing; YANG, Li-ping; LIU, Ru-shi; YAN, Feng; ZHANG, Jian

Source: Acta Pharmacologica Sinica, Volume 29, Number 4, April 2008 , pp. 465-472(8)

Publisher: Blackwell Publishing

Doxazosin in the current treatment of hypertension

Authors: Wykretowicz, Andrzej; Guzik, Przemyslaw; Wysocki, Henryk

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 4, March 2008 , pp. 625-633(9)

Publisher: Informa Healthcare

Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty

Authors: Seftel, A. D.; Rosen, R. C.; Rosenberg, M. T.; Sadovsky, R.

Source: International Journal of Clinical Practice, Volume 62, Number 4, April 2008 , pp. 614-622(9)

Publisher: Blackwell Publishing

Early HIET safe in CCB-induced cardiovascular toxicity

Source: Reactions, Volume 1, Number 1183, 2008-01-05 , pp. 4-4(1)

Publisher: Adis International